Khunfoti thanks for this, an excellent article, all very positive however the paragraph I have extracted below is the biggest source of my frustration coming purely from an investment point of view. I have said it before, I'm not sure the announcement of CHF phase 3 will do that much to the share price given that we are taking about a trial that will go for 3 years
": Going to Mesoblast, since the company is just starting its 1,700-patient phase 3 trial in CHF, it's three years away from any good data on that indication. I'm thinking that one of the big value drivers for the company right now is intervertebral disc disease. "
Let's hope this Thursdays presentation on disk moves the share price up a little. A pharma deal would be great to.
Thx
5.50, page-17
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.46 |
Change
0.065(4.66%) |
Mkt cap ! $1.667B | |||
| Open | High | Low | Value | Volume |
| $1.41 | $1.50 | $1.40 | $5.699M | 3.943M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 122380 | $1.46 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.46 | 11015 | 2 |
View Market Depth
| Last trade - 16.10pm 11/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |